Suppr超能文献

呼吸性流感病毒载量作为严重症状患者预后不良的标志物。

Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms.

机构信息

Virology Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut De Recherche En Santé, Environnement Et Travail) - UMR_S 1085, F-35000 Rennes, France.

Maladies Infectieuses Et Réanimation Médicale, CHU Rennes, Inserm-CIC 1414, Biosit, F-35043 Rennes, France.

出版信息

J Clin Virol. 2021 Mar;136:104761. doi: 10.1016/j.jcv.2021.104761. Epub 2021 Feb 12.

Abstract

BACKGROUND

The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU).

METHODS

Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014-2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission.

RESULTS

Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log) in each respiratory sample ranged from 20 to 40 and -5.2-3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p < 0.05).

CONCLUSIONS

While IV-VL does not seem to predict disease evolution in ICU flu-patients, normalized measurement of IV-VL in respiratory samples could be useful in ARDS patients to identify patients at higher risk of mortality.

摘要

背景

流感病毒(IV)在呼吸道样本中的病毒载量(VL)与疾病严重程度之间的联系尚不清楚。本研究旨在评估重症监护病房(ICU)收治的流感患者的呼吸道样本中的 IV-VL。

方法

在 5 个流感季节(2014-2018 年)期间,将经 RT-PCR 确诊为 IV 感染且呼吸衰竭而入住 ICU 的患者纳入本研究。记录常规 ICU 管理参数。在 ICU 入院时采集的每个呼吸道样本中测量 IV 和细胞 GAPDH 基因的实时扩增 Ct 值。

结果

在 105 例纳入患者中,有 59 例(56.1%)发生急性呼吸窘迫综合征(ARDS)。总体死亡率为 21%。每个呼吸道样本的扩增 Ct 值评估的 IV 载量和病毒与细胞的比值(以对数表示)分别为 20 到 40 和-5.2 到 3.7,且与样本类型和 IV-A 或 -B 类型无关。ARDS 患者的样本细胞丰富度高于非 ARDS 患者(p=0.0003),但 IV Ct 值无差异。在 ARDS 患者中,最终死亡患者的 IV Ct 值(p=0.020)和病毒与细胞的比值(p=0.038)均显著高于存活患者。这两个参数与死亡率独立相关,优势比分别为 1.21 和 2.19(p<0.05)。

结论

虽然 IV-VL 似乎不能预测 ICU 流感患者的疾病进展,但在 ARDS 患者中对呼吸道样本中 IV-VL 进行归一化测量可能有助于识别死亡率较高的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验